Tivanidazole
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101692This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E136TJT00. European Medicines Agency schedules Tivanidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11123MIG. Tivanidazole generally arises in the molecular formula C11H13N5O2S. The term TIVANIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) TIVANIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tivanidazole under HS 29349990 and SITC 51579. As of Q4 2014, TIVANIDAZOLE remains the US FDA Preferred Term for this commodity. Tivanidazole bears US NLM identifiers UMLS ID C2348794 and NCI Concept Code C73279. SMILES: CCC1=NN=C(S1)/C(=C/C2=NC=C(N2C)[N+](=O)[O-])/C.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.